ResMed announces board change

Friday, November 17, 2017

SAN DIEGO – ResMed has named Karen Drexler to its board of directors, the company has announced. Drexler is CEO and board member of Bay area biotech company Sandstone Diagnostics, and has extensive healthcare management experience. "I'm thrilled to welcome Karen Drexler to ResMed's Board," said ResMed Founder and Board Chairman Peter Farrell. "Her deep expertise in advising and managing medical device, digital health and diagnostic companies, and particularly her experience in technology and out-of-hospital care models, will serve ResMed well as we continue to deepen our leadership in connected care and digital health." Drexler replaces Dr. Chris Roberts, who has retired after serving more than 25 years on the board.